Dr. Tola Introduces TMS Therapy as a Safe and Effective Alternative for Treating Depression

Wellesley, MA (Newsworthy.ai) Wednesday Jan 17, 2024 @ 12:00 PM Australia/Perth —

Dr. Tola T’Sarumi, a recognized psychiatrist and emotional wellness strategist, offers the latest TMS Therapy as a fresh healing procedure for those suffering from depression. TMS Therapy, which is medicine-free and non-invasive, uses magnetic pulses to target the part of the brain involved in mood regulation.

A significant advantage of TMS Therapy is its convenience. The sessions, lasting only 20 minutes, can be conducted during a lunch hour with no post-treatment downtime. Additionally, NeuroStar, the leading brand used for TMS Therapy, is noted for its effectiveness and minimal side effects.

Besides TMS Therapy, Dr. Tola provides a variety of resources to enhance mental health and overall well-being. She maintains a thought-provoking blog that discusses issues related to mental health, wellness, living, and relationships, offering readers valuable advice. Additionally, Dr. Tola has wellness products for sale, aimed at improving emotional well-being.

Dr. Tola's work has earned her considerable recognition and media exposure. Her expertise is frequently cited in various media outlets. Her dedication to fostering a safe and caring environment for her patients has established him as a devoted and trusted professional in the field of psychiatry.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Dr. Tola Introduces TMS Therapy as a Safe and Effective Alternative for Treating Depression.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  198.95
-5.13 (-2.51%)
AAPL  261.31
-14.19 (-5.15%)
AMD  206.63
-6.95 (-3.25%)
BAC  52.63
-1.22 (-2.26%)
GOOG  310.55
-0.78 (-0.25%)
META  651.75
-16.94 (-2.53%)
MSFT  404.12
-0.25 (-0.06%)
NVDA  189.12
-0.94 (-0.49%)
ORCL  157.38
+0.22 (0.14%)
TSLA  414.44
-13.83 (-3.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.